Moreover, the BCL2L1 pre-mRNA is associated with greater tumor cell survival in various cancer types including human lymphoma, breast cancer, prostate cancer, and human hepatocellular carcinoma37,38. This evidence concerns the gene BCL2L1 and Familial prostate cancer.